<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Australian Patent Office:  Patent Term Extension Available If Has Pharmaceutical Characteristics</title>
	<atom:link href="http://www.patentbaristas.com/archives/2009/06/16/australian-patent-office-patent-term-extension-available-if-has-pharmaceutical-characteristics/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patentbaristas.com/archives/2009/06/16/australian-patent-office-patent-term-extension-available-if-has-pharmaceutical-characteristics/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=australian-patent-office-patent-term-extension-available-if-has-pharmaceutical-characteristics</link>
	<description>Freshly Brewed Bio/Pharma Chat. Served Up Daily.</description>
	<lastBuildDate>Tue, 15 May 2012 15:53:19 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
	<item>
		<title>By: Australian Pharmaceutical Patent Term Extension for Patches and Implants &#124; Technology Boss</title>
		<link>http://www.patentbaristas.com/archives/2009/06/16/australian-patent-office-patent-term-extension-available-if-has-pharmaceutical-characteristics/comment-page-1/#comment-69451</link>
		<dc:creator>Australian Pharmaceutical Patent Term Extension for Patches and Implants &#124; Technology Boss</dc:creator>
		<pubDate>Wed, 26 Aug 2009 14:40:36 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/?p=1725#comment-69451</guid>
		<description>[...] by admin on Aug.26, 2009, under BioTech Bill Bennett, of Pizzeys in Australia, sent the note detailing how in sequence to be authorised for an prolongation of term, the obvious in subject contingency explain “one or some-more curative substances per se”, as well as there contingency have been the check of some-more than 5 years in in between the date upon that the obvious was filed as well as the date of initial selling approval.  See the progressing outline of the eligibility mandate for curative obvious tenure extension. [...]</description>
		<content:encoded><![CDATA[<p>[...] by admin on Aug.26, 2009, under BioTech Bill Bennett, of Pizzeys in Australia, sent the note detailing how in sequence to be authorised for an prolongation of term, the obvious in subject contingency explain “one or some-more curative substances per se”, as well as there contingency have been the check of some-more than 5 years in in between the date upon that the obvious was filed as well as the date of initial selling approval.  See the progressing outline of the eligibility mandate for curative obvious tenure extension. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Patent Baristas &#187; Australian Pharmaceutical Patent Term Extension for Patches and Implants</title>
		<link>http://www.patentbaristas.com/archives/2009/06/16/australian-patent-office-patent-term-extension-available-if-has-pharmaceutical-characteristics/comment-page-1/#comment-69446</link>
		<dc:creator>Patent Baristas &#187; Australian Pharmaceutical Patent Term Extension for Patches and Implants</dc:creator>
		<pubDate>Tue, 25 Aug 2009 20:30:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/?p=1725#comment-69446</guid>
		<description>[...] Bill Bennett, of Pizzeys in Australia, sent a note detailing how in order to be eligible for an extension of term, the patent in question must claim “one or more pharmaceutical substances per se”, and there must have been a delay of more than 5 years between the date on which the patent was filed and the date of first marketing approval.  See the earlier description of the eligibility requirements for pharmaceutical patent term extension. [...]</description>
		<content:encoded><![CDATA[<p>[...] Bill Bennett, of Pizzeys in Australia, sent a note detailing how in order to be eligible for an extension of term, the patent in question must claim “one or more pharmaceutical substances per se”, and there must have been a delay of more than 5 years between the date on which the patent was filed and the date of first marketing approval.  See the earlier description of the eligibility requirements for pharmaceutical patent term extension. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Served from: www.patentbaristas.com @ 2012-05-16 19:32:56 -->
